Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
50 hedge funds and large institutions have $14.3M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 10 closing their positions.
731% more call options, than puts
Call options by funds: $216K | Put options by funds: $26K
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
0% more funds holding
Funds holding: 50 → 50 (0)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
62% less capital invested
Capital invested by funds: $37.3M → $14.3M (-$22.9M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$2.09M |
| 2 |
VFA
Values First Advisors
Gray,
Tennessee
|
+$239K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$154K |
| 4 |
Goldman Sachs
New York
|
+$146K |
| 5 |
ED
Exane Derivatives
Paris,
France
|
+$100K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$4.58M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.28M |
| 3 |
Renaissance Technologies
New York
|
-$1.04M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$818K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$271K |
NBRV Hedge Fund Activity: Q1 2020 in Review
50 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q1 2020, worth a combined $14.3M — down 62% from $37.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NBRV positions and 10 closed out — a net gain of 2 holders — while 10 added to existing stakes and 13 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $2.09M. The largest seller was CVI Holdings, exiting entirely with an estimated $4.58M sold.
- 50 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $14.3M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q1 2020, down 62% quarter-over-quarter.
- 12 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q1 2020 and 10 closed out, a net change of +2 holders.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q1 2020 was Vivo Capital, an estimated $2.09M added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q1 2020 was CVI Holdings, an estimated $4.58M sold.
Based on aggregated 13F filings for Q1 2020.